Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released Aug 10, 2023, after the close
10-Q filed Aug 10, 2023, 41 days after period end · 0000950170-23-041362
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$22.94M | -$20.29M | -$21.01M | -$11.02M |
| EPS Diluted | -$0.50 | -$0.51 | -$0.57 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR